Immune Gene–Viral Therapy with Triplex Efficacy Mediated by Oncolytic Adenovirus Carrying an Interferon-γ Gene Yields Efficient Antitumor Activity in Immunodeficient and Immunocompetent Mice
Open Access
- 1 May 2006
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 13 (5) , 918-927
- https://doi.org/10.1016/j.ymthe.2005.12.011
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Potent antitumor efficacy of an E1B 55kDa-deficient adenovirus carrying murineendostatin in hepatocellular carcinomaInternational Journal of Cancer, 2004
- Effective Gene-Viral Therapy for Telomerase-Positive Cancers by Selective Replicative-Competent Adenovirus Combining with Endostatin GeneCancer Research, 2004
- Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cellsZeitschrift für Krebsforschung und Klinische Onkologie, 2004
- Vaccine-induced CD8+ T cells eliminate tumors by a two-staged attackCancer Gene Therapy, 2003
- Telomerase-dependent oncolytic adenovirus for cancer treatmentGene Therapy, 2003
- Replicative Oncolytic Adenoviruses in Multimodal Cancer RegimensHuman Gene Therapy, 2003
- A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanomaCancer Gene Therapy, 2003
- Armed therapeutic viruses: Strategies and challenges to arming oncolytic viruses with therapeutic genesCancer Gene Therapy, 2002
- Regression of primary hepatocarcinoma in cancer-prone transgenic mice by local interferon-γ delivery is associated with macrophages recruitment and nitric oxide productionCancer Gene Therapy, 2001
- The neglected role of type I interferon in the T-cell response: implications for its clinical useImmunology Today, 1996